An other cross-sectional analysis showed that subjects with severe asthma at follow-up had poorer FEV1% predicted at baseline, poorer symptom control, higher IgE levels, and higher prevalence of chronic cough/mucus hypersecretion than patients with intermittent asthma. The gene discussed is IGHE; the disease is asthma.